These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36822167)

  • 1. High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study.
    Konermann FM; Gessler N; Wohlmuth P; Behr J; Feldhege J; Gloeckner C; Gunawardene MA; Herrlinger KR; Hoelting T; Pape UF; Reinmuth N; Stang A; Sheikhzadeh S; Arnold D; Wesseler C
    Oncol Res Treat; 2023; 46(5):201-210. PubMed ID: 36822167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland.
    Portmann L; de Kraker MEA; Fröhlich G; Thiabaud A; Roelens M; Schreiber PW; Troillet N; Iten A; Widmer A; Harbarth S; Sommerstein R;
    JAMA Netw Open; 2023 Feb; 6(2):e2255599. PubMed ID: 36790812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of influenza and COVID-19 inpatients in different phases of the SARS-CoV-2 pandemic: a single-centre retrospective case-control study.
    Bechmann L; Esser T; Färber J; Kaasch A; Geginat G
    J Hosp Infect; 2023 Aug; 138():1-7. PubMed ID: 37127148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany study.
    Dickow J; Gunawardene MA; Willems S; Feldhege J; Wohlmuth P; Bachmann M; Bergmann MW; Gesierich W; Nowak L; Pape UF; Schreiber R; Wirtz S; Twerenbold R; Sheikhzadeh S; Gessler N
    PLoS One; 2023; 18(9):e0292017. PubMed ID: 37756299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality.
    Jank M; Oechsle AL; Armann J; Behrends U; Berner R; Chao CM; Diffloth N; Doenhardt M; Hansen G; Hufnagel M; Lander F; Liese JG; Muntau AC; Niehues T; von Both U; Verjans E; Weil K; von Kries R; Schroten H
    Infection; 2023 Oct; 51(5):1357-1367. PubMed ID: 36787015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods - United States, April 2020-June 2022.
    Adjei S; Hong K; Molinari NM; Bull-Otterson L; Ajani UA; Gundlapalli AV; Harris AM; Hsu J; Kadri SS; Starnes J; Yeoman K; Boehmer TK
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(37):1182-1189. PubMed ID: 36107788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deaths Due to COVID-19 in Patients With Cancer During Different Waves of the Pandemic in the US.
    Potter AL; Vaddaraju V; Venkateswaran S; Mansur A; Bajaj SS; Kiang MV; Jena AB; Yang CJ
    JAMA Oncol; 2023 Oct; 9(10):1417-1422. PubMed ID: 37651113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of mortality and severe illness in patients infected with the omicron variant relative to delta variant of SARS-CoV-2: a systematic review and meta-analysis.
    Kow CS; Ramachandram DS; Hasan SS
    Ir J Med Sci; 2023 Dec; 192(6):2897-2904. PubMed ID: 36754948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective study.
    Guo Y; Guo Y; Ying H; Yu W; Chen S; Zhang Y; Zhang S; Lin Y; Sun F; Zhang Y; Yu J; Ma K; Qin L; Long F; Zhu H; Mao R; Xue J; Zhang J
    BMC Infect Dis; 2023 Oct; 23(1):698. PubMed ID: 37853317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway.
    Stålcrantz J; Kristoffersen AB; Bøås H; Veneti L; Seppälä E; Aasand N; Hungnes O; Kvåle R; Bragstad K; Buanes EA; Whittaker R
    Scand J Public Health; 2022 Aug; 50(6):676-682. PubMed ID: 35799474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of hospital-acquired SARS-CoV-2 infections in Germany: occurrence and outcomes of different variants.
    Bonsignore M; Hohenstein S; Kodde C; Leiner J; Schwegmann K; Bollmann A; Möller R; Kuhlen R; Nachtigall I
    J Hosp Infect; 2022 Nov; 129():82-88. PubMed ID: 35995339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital mortality of older patients with COVID-19 throughout the epidemic waves in the great Paris area: a multicenter cohort study.
    Thietart S; Rozes A; Tubach F; Marot S; Marcelin AG; Raux M; Vallet H; Riou B; Boddaert J; Zerah L
    BMC Geriatr; 2023 Sep; 23(1):573. PubMed ID: 37723419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
    Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
    Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial SARS-CoV-2 transmission in multi-bedded hospital cubicles over successive pandemic waves: Lower mortality but wider spread with Omicron despite enhanced infection-prevention measures.
    Wee LE; Conceicao EP; Aung MK; Aung MO; Yang Y; Arora S; Ko KK; Venkatachalam I
    Infect Dis Health; 2023 May; 28(2):81-87. PubMed ID: 37032572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study.
    Schmidt M; Hajage D; Landoll M; Pequignot B; Langouet E; Amalric M; Mekontso-Dessap A; Chiscano-Camon L; Surman K; Finnerty D; Santa-Teresa P; Arcadipane A; Millán P; Roncon-Albuquerque R; Blandino-Ortiz A; Blanco-Schweizer P; Ricart P; Gimeno-Costa R; Albacete CL; Fortuna P; Schellongowski P; Dauwe D; Winiszewski H; Kimmoun A; Levy B; Hermans G; Grasselli G; Lebreton G; Guervilly C; Martucci G; Karagiannidis C; Riera J; Combes A;
    Lancet Respir Med; 2023 Feb; 11(2):163-175. PubMed ID: 36640786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Analysis of In-Hospital Mortality per Disease Groups in Germany Before and During the COVID-19 Pandemic From 2016 to 2020.
    König S; Pellissier V; Hohenstein S; Leiner J; Hindricks G; Meier-Hellmann A; Kuhlen R; Bollmann A
    JAMA Netw Open; 2022 Feb; 5(2):e2148649. PubMed ID: 35166779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study.
    Sankar K; Modi N; Polyak A; Directo MP; Johnson LR; Kho N; Isonaka SK; Pedraza I; Chen P; Modes ME
    BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36805880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection.
    Tsakok MT; Watson RA; Saujani SJ; Kong M; Xie C; Peschl H; Wing L; MacLeod FK; Shine B; Talbot NP; Benamore RE; Eyre DW; Gleeson F
    Radiology; 2023 Jan; 306(1):261-269. PubMed ID: 35727150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase.
    Aggarwal NR; Beaty LE; Bennett TD; Carlson NE; Mayer DA; Molina KC; Peers JL; Russell S; Wynia MK; Ginde AA
    Int J Infect Dis; 2023 Mar; 128():310-317. PubMed ID: 36229005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.